ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Animals  (4)
  • 2000-2004  (2)
  • 1990-1994  (2)
Collection
Keywords
Publisher
Years
Year
  • 1
    facet.materialart.
    Unknown
    CNS synaptogenesis promoted by glia-derived cholesterol (2001)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 2001-11-10
    Description: The molecular mechanisms controlling synaptogenesis in the central nervous system (CNS) are poorly understood. Previous reports showed that a glia-derived factor strongly promotes synapse development in cultures of purified CNS neurons. Here, we identify this factor as cholesterol complexed to apolipoprotein E-containing lipoproteins. CNS neurons produce enough cholesterol to survive and grow, but the formation of numerous mature synapses demands additional amounts that must be provided by glia. Thus, the availability of cholesterol appears to limit synapse development. This may explain the delayed onset of CNS synaptogenesis after glia differentiation and neurobehavioral manifestations of defects in cholesterol or lipoprotein homeostasis.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Mauch, D H -- Nagler, K -- Schumacher, S -- Goritz, C -- Muller, E C -- Otto, A -- Pfrieger, F W -- New York, N.Y. -- Science. 2001 Nov 9;294(5545):1354-7.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Synapse Group and, Protein Chemistry Group, Max-Delbruck-Center for Molecular Medicine, D-13092 Berlin, Germany.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/11701931" target="_blank"〉PubMed〈/a〉
    Keywords: Animals ; Anticholesteremic Agents/pharmacology ; Apolipoproteins E/metabolism ; Cells, Cultured ; Cholesterol/*metabolism/pharmacology ; Culture Media, Conditioned ; Excitatory Postsynaptic Potentials ; Lovastatin/*analogs & derivatives/pharmacology ; Neuroglia/*metabolism ; Patch-Clamp Techniques ; Phosphatidylcholines/pharmacology ; Rats ; Rats, Sprague-Dawley ; Retinal Ganglion Cells/metabolism/*physiology ; Sphingomyelins/pharmacology ; Synapses/drug effects/*physiology ; Synaptic Transmission
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 2
    facet.materialart.
    Unknown
    Behavioral effects of progesterone associated with rapid modulation of oxytocin receptors (1990)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1990-11-02
    Description: The ventromedial nuclei of the hypothalamus (VMN) are important for the control of feminine mating behavior, and hormone action within these nuclei has been causally related to behavior. Estradiol induces receptors for oxytocin in the VMN and in the area lateral to these nuclei over the course of 1 to 2 days, and progesterone causes, within 30 minutes of its application, a further increase in receptor binding and an expansion of the area covered by these receptors lateral to the VMN. The rapid progesterone effect appears to be a direct and specific effect of this steroid on the receptor or membrane, because it was produced in vitro as well as in vivo and was not mimicked by a variety of other steroids. The effect of progesterone occurred in the posterior part of the VMN, where oxytocin infusion facilitated feminine mating behavior; it did not take place in the anterior part of the VMN, where oxytocin infusion had no effect on mating behavior.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Schumacher, M -- Coirini, H -- Pfaff, D W -- McEwen, B S -- HD-05751/HD/NICHD NIH HHS/ -- NS-07080/NS/NINDS NIH HHS/ -- TWO4103/TW/FIC NIH HHS/ -- New York, N.Y. -- Science. 1990 Nov 2;250(4981):691-4.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Laboratory of Neuroendocrinology, Rockefeller University, New York, NY 10021.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/2173139" target="_blank"〉PubMed〈/a〉
    Keywords: Animals ; Estradiol/pharmacology ; Female ; Oxytocin/pharmacology ; Progesterone/*pharmacology ; Rats ; Receptors, Angiotensin/*drug effects/metabolism ; Receptors, Oxytocin ; Sexual Behavior, Animal/*drug effects ; Ventromedial Hypothalamic Nucleus/*drug effects
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 3
    facet.materialart.
    Unknown
    Antigen bias in T cell cross-priming (2004)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 2004-05-29
    Description: Activated CD8+ T cells detect virally infected cells and tumor cells by recognition of major histocompatibility complex class I-bound peptides derived from degraded, endogenously produced proteins. In contrast, CD8+ T cell activation often occurs through interaction with specialized antigen-presenting cells displaying peptides acquired from an exogenous cellular source, a process termed cross-priming. Here, we observed a marked inefficiency in exogenous presentation of epitopes derived from signal sequences in mouse models. These data indicate that certain virus- and tumor-associated antigens may not be detected by CD8+ T cells because of impaired cross-priming. Such differences in the ability to cross-present antigens should form important considerations in vaccine design.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Wolkers, Monika C -- Brouwenstijn, Nathalie -- Bakker, Arnold H -- Toebes, Mireille -- Schumacher, Ton N M -- New York, N.Y. -- Science. 2004 May 28;304(5675):1314-7.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/15166378" target="_blank"〉PubMed〈/a〉
    Keywords: Animals ; *Antigen Presentation ; Antigens, Viral/genetics/*immunology ; CD8-Positive T-Lymphocytes/*immunology ; Cell Line, Tumor ; *Cross-Priming ; Dendritic Cells/immunology ; Epitopes, T-Lymphocyte/*immunology ; Immune Tolerance ; Immunoglobulins/immunology/metabolism ; Influenza A virus/immunology ; Lymphocyte Activation ; Mice ; Papillomaviridae/immunology ; Protein Sorting Signals/genetics ; Recombinant Fusion Proteins/immunology ; T-Lymphocytes, Cytotoxic/immunology ; Transfection ; Vaccines/immunology
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
  • 4
    facet.materialart.
    Unknown
    Peptide translocation by variants of the transporter associated with antigen processing (1993)
    American Association for the Advancement of Science (AAAS)
    Details
    Publication Date: 1993-12-24
    Description: Major histocompatibility complex (MHC) class I molecules associate with peptides that are delivered from the cytosol to the lumen of the endoplasmic reticulum by the transporter associated with antigen processing (TAP). Liver microsomes of SHR and Lewis rats, which express different alleles of TAP (cim(b) and cim(a), respectively), accumulate different sets of peptides. Use of MHC congenic rats assigned this difference to the MHC, independent of the class I products expressed. Both the cim(a) and cim(b) TAP complexes translocate peptides with a hydrophobic carboxyl terminus, but translocation of peptides with a carboxyl-terminal His, Lys, or Arg residue is unique to cim(a). Thus, the specificity of the TAP peptide translocator restricts the peptides available for antigen presentation.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Heemels, M T -- Schumacher, T N -- Wonigeit, K -- Ploegh, H L -- R01 AI3 3456-01/AI/NIAID NIH HHS/ -- New York, N.Y. -- Science. 1993 Dec 24;262(5142):2059-63.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Biology, Massachusetts Institute of Technology, Cambridge 02139.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/8266106" target="_blank"〉PubMed〈/a〉
    Keywords: *ATP-Binding Cassette Transporters ; Alleles ; Amino Acid Sequence ; Animals ; Antigen Presentation/*physiology ; Biological Transport/physiology ; Carrier Proteins/genetics/*physiology ; Histocompatibility Antigens Class I/physiology ; Histocompatibility Antigens Class II/genetics/*physiology ; In Vitro Techniques ; Microsomes, Liver/metabolism ; Molecular Sequence Data ; Oligopeptides/*metabolism ; Rats ; Rats, Inbred BN ; Rats, Inbred Lew ; Rats, Inbred SHR ; Substrate Specificity
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Published by American Association for the Advancement of Science (AAAS)
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
    PAPER CURRENT
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...